Performance of JAZZ Jazz Pharmaceuticals PLC | -22% in 12m
Compare JAZZ with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Jazz Pharmaceuticals PLC with its related Sector/Index XLV
Performance Duell JAZZ vs XLV
| TimeFrame | JAZZ | XLV |
|---|---|---|
| 1 Day | -0.40% | -0.07% |
| 1 Week | 1.84% | -0.69% |
| 1 Month | -7.29% | -4.19% |
| 3 Months | -10.8% | 0.33% |
| 6 Months | -13.4% | 13.59% |
| 12 Months | -22.0% | 6.27% |
| YTD | -13.1% | 1.48% |
| Rel. Perf. 1m | -0.37 | |
| Rel. Perf. 3m | -1.55 | |
| Rel. Perf. 6m | -2.67 | |
| Rel. Perf. 12m | -2.95 |
Is Jazz Pharmaceuticals PLC a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.54 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JAZZ as of May 2024 is 99.44. This means that JAZZ is currently overvalued and has a potential downside of -10.21% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JAZZ as of May 2024 is 99.44. This means that JAZZ is currently overvalued and has a potential downside of -10.21% (Sold with Premium).
Is JAZZ a buy, sell or hold?
- Strong Buy: 9
- Buy: 6
- Hold: 4
- Sell: 0
- Strong Sell: 0
Values above 0%: JAZZ is performing better - Values below 0%: JAZZ is underperforming
Compare JAZZ with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.84% | -3.11% | -32.60% | -44.13% |
| US NASDAQ 100 | QQQ | 3.01% | -2.02% | -31.91% | -53.67% |
| US Dow Jones Industrial 30 | DIA | 3.28% | -3.18% | -28.33% | -35.45% |
| German DAX 40 | DBXD | 3.05% | -5.29% | -34.40% | -35.43% |
| UK FTSE 100 | ISFU | -0.12% | -9.84% | -30.27% | -31.34% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.99% | -7.86% | -14.78% | -9.31% |
| Hongkong Hang Seng | HSI | -2.22% | -10.36% | -11.82% | -2.72% |
| Japan Nikkei 225 | EXX7 | 2.21% | -1.27% | -30.31% | -40.93% |
| India NIFTY 50 | INDA | 1.07% | -9.08% | -34.13% | -49.67% |
| Brasil Bovespa | EWZ | 1.32% | -5.15% | -18.57% | -39.84% |
JAZZ Jazz Pharmaceuticals PLC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.47% | -1.91% | -34.29% | -53.19% |
| Consumer Discretionary | XLY | 0.05% | -3.51% | -29.29% | -42.86% |
| Consumer Staples | XLP | 1.65% | -6.96% | -26.30% | -22.24% |
| Energy | XLE | 4.54% | -5.62% | -25.10% | -36.92% |
| Financial | XLF | 3.71% | -3.64% | -39.18% | -46.15% |
| Health Care | XLV | 2.53% | -3.10% | -26.96% | -28.24% |
| Industrial | XLI | 3.10% | -4.51% | -37.98% | -44.87% |
| Materials | XLB | 1.44% | -2.93% | -31.13% | -34.32% |
| Real Estate | XLRE | 2.69% | -0.47% | -24.62% | -22.19% |
| Technology | XLK | 2.28% | -1.27% | -33.50% | -53.08% |
| Utilities | XLU | 1.24% | -9.57% | -27.17% | -21.88% |
| Aerospace & Defense | XAR | 1.20% | -5.09% | -31.99% | -41.16% |
| Biotech | XBI | 1.92% | 2.54% | -41.16% | -25.10% |
| Homebuilder | XHB | 2.81% | -0.45% | -57.15% | -68.52% |
| Retail | XRT | 3.55% | 1.21% | -36.50% | -41.20% |
Does Jazz Pharmaceuticals PLC outperform its market, is JAZZ a Sector Leader?
No, over the last 12 months Jazz Pharmaceuticals PLC (JAZZ) made -21.97%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.27%.
Over the last 3 months JAZZ made -10.81%, while XLV made 0.33%.
No, over the last 12 months Jazz Pharmaceuticals PLC (JAZZ) made -21.97%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.27%.
Over the last 3 months JAZZ made -10.81%, while XLV made 0.33%.
| Period | JAZZ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -7.29% | -4.19% | -4.18% |
| 3 Months | -10.81% | 0.33% | 2.60% |
| 12 Months | -21.97% | 6.27% | 22.16% |